European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - November 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 November 2026, 14:00 (CET) to 26 November 2026, 18:00 (CET)

Submitted by Anonymous (not verified) on 21 May 2026 - 9:22

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - November 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 November 2026, 14:00 (CET) to 26 November 2026, 18:00 (CET)

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 October 2026, 09:00 (CEST) to 8 October 2026, 13:00 (CEST)

Submitted by Anonymous (not verified) on 21 May 2026 - 9:21

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 October 2026, 09:00 (CEST) to 8 October 2026, 13:00 (CEST)

Human medicines European public assessment report (EPAR): Ruconest, conestat alfa, Date of authorisation: 28/10/2010, Revision: 16, Status: Authorised

Submitted by Anonymous (not verified) on 20 May 2026 - 16:48

Human medicines European public assessment report (EPAR): Ruconest, conestat alfa, Date of authorisation: 28/10/2010, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Feraccru, ferric maltol, Date of authorisation: 18/02/2016, Revision: 19, Status: Authorised

Submitted by Anonymous (not verified) on 20 May 2026 - 16:41

Human medicines European public assessment report (EPAR): Feraccru, ferric maltol, Date of authorisation: 18/02/2016, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Date of authorisation: 16/07/2021, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 20 May 2026 - 16:32

Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Date of authorisation: 16/07/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Xofluza, baloxavir marboxil, Date of authorisation: 07/01/2021, Revision: 9, Status: Authorised

Submitted by Anonymous (not verified) on 20 May 2026 - 16:17

Human medicines European public assessment report (EPAR): Xofluza, baloxavir marboxil, Date of authorisation: 07/01/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Mimpara, cinacalcet, Date of authorisation: 22/10/2004, Revision: 27, Status: Withdrawn

Submitted by Anonymous (not verified) on 20 May 2026 - 15:55

Human medicines European public assessment report (EPAR): Mimpara, cinacalcet, Date of authorisation: 22/10/2004, Revision: 27, Status: Withdrawn

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 14 September 2026 to 18 September 2026

Submitted by Anonymous (not verified) on 20 May 2026 - 15:47

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 14 September 2026 to 18 September 2026

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness